Evidence map›Paper›PMID 33341919›Full record

ArticleBrain structure & function2021

Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain.

Erzsébet Farkas, Anett Szilvásy-Szabó, Yvette Ruska, Richárd Sinkó, Morten Grønbech Rasch, Thomas Egebjerg, Charles Pyke, Balázs Gereben, Lotte Bjerre Knudsen, Csaba Fekete

Open access · hybridAbstract read
In one paragraph

Article in Brain structure & function, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. The complexity of pain in osteoarthritis.Nature reviews. Rheumatology · 2026
    Review
  7. The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Erzsébet FarkasLaboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, 1083, Hungary.
Anett Szilvásy-SzabóLaboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, 1083, Hungary.
Yvette RuskaLaboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, 1083, Hungary.
Richárd SinkóLaboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, 1083, Hungary.
Morten Grønbech RaschNovo Nordisk A/S, 2760, Måløv, Denmark.
Thomas EgebjergNovo Nordisk A/S, 2760, Måløv, Denmark.
Charles PykeNovo Nordisk A/S, 2760, Måløv, Denmark.
Balázs GerebenLaboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, 1083, Hungary.
Lotte Bjerre KnudsenNovo Nordisk A/S, 2760, Måløv, Denmark.
Csaba FeketeLaboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, 1083, Hungary. csaba.fekete@koki.hu.ORCID http://orcid.org/0000-0002-8206-562X
HUN-REN Institute of Experimental Medicine · HUNovo Nordisk (Denmark) · DKTufts Medical Center · US

Funding

H2020 Excellent Science THYRAGE no. 666869Nemzeti Agykutatási Program 2017-1.2.1-NKP-2017-00002
6 · The paper itself

Abstract

Glucagon-like peptide-1 (GLP-1) inhibits food intake and regulates glucose homeostasis. These actions are at least partly mediated by central GLP-1 receptor (GLP-1R). Little information is available, however, about the subcellular localization and the distribution of the GLP-1R protein in the rat brain. To determine the localization of GLP-1R protein in the rat brain, immunocytochemistry was performed at light and electron microscopic levels. The highest density of GLP-1R-immunoreactivity was observed in the circumventricular organs and regions in the vicinity of these areas like in the arcuate nucleus (ARC) and in the nucleus tractus solitarii (NTS). In addition, GLP-1R-immunreactive (IR) neuronal profiles were also observed in a number of telencephalic, diencephalic and brainstem areas and also in the cerebellum. Ultrastructural examination of GLP-1R-immunoreactivity in energy homeostasis related regions showed that GLP-1R immunoreactivity is associated with the membrane of perikarya and dendrites but GLP-1R can also be observed inside and on the surface of axon varicosities and axon terminals. In conclusion, in this study we provide a detailed map of the GLP-1R-IR structures in the CNS. Furthermore, we demonstrate that in addition to the perikaryonal and dendritic distribution, GLP-1R is also present in axonal profiles suggesting a presynaptic action of GLP-1. The very high concentration of GLP-1R-profiles in the circumventricular organs and in the ARC and NTS suggests that peripheral GLP-1 may influence brain functions via these brain areas.

Indexed as

AnimalsBrainGlucagon-Like Peptide-1 ReceptorImmunohistochemistryMaleNeuronsRatsRats, Sprague-DawleyGlp1r protein, ratGlucagon-Like Peptide-1 ReceptorAxonal localizationDistributionElectron microscopyGLP-1 receptorImmunohistochemistry

Identifiers

PMID33341919
PMCPMC7817608
OpenAlexW3117625807

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.